z-logo
open-access-imgOpen Access
Vascular cell-adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress
Author(s) -
Aling Dong,
Jikui Shen,
Ming Bing Zeng,
Peter A. Campochiaro
Publication year - 2011
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1012859108
Subject(s) - oxidative stress , ischemia , sod1 , cell adhesion molecule , superoxide dismutase , vcam 1 , neovascularization , pharmacology , medicine , endocrinology , immunology , angiogenesis , icam 1
Oxidative stress exacerbates neovascularization (NV) in many disease processes. In this study we investigated the mechanism of that effect. Mice deficient in superoxide dismutase 1 (Sod1−/− mice) have increased oxidative stress and show severe ocular NV that is reduced to baseline by antioxidants. Compared with wild-type mice with ischemic retinopathy,Sod1−/− mice with ischemic retinopathy had increased expression of several NF-κB–responsive genes, but expression ofvascular cell-adhesion molecule-1 (Vcam1 ) was particularly high. Intraocular injection of anti–VCAM-1 antibody eliminated the excessive ischemia-induced retinal NV. Elements that contributed to oxidative stress-induced worsening of retinal NV that were abrogated by blockade of VCAM-1 included increases in leukostasis, influx of bone marrow-derived cells, and capillary closure. Compared with ischemia alone, ischemia plus oxidative stress resulted in increased expression of several HIF-1–responsive genes caused in part by VCAM-1–induced worsening of nonperfusion and, hence, ischemia, because anti–VCAM-1 significantly reduced the increased expression of all but one of the genes. These data explain why oxidative stress worsens ischemia-induced retinal NV and may be relevant to other neovascular diseases in which oxidative stress has been implicated. The data also suggest that antagonism of VCAM-1 provides a potential therapy to combat worsening of neovascular diseases by oxidative stress.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here